[Conception and systematics of clinical follow-up therapy of mammary carcinoma (author's transl)].
D000359:Aftercare; D045930:Anabolic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery*; D001945:Breathing Exercises; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011183:Postoperative Complications / Q000178:diet therapy / Q000188:drug therapy / Q000532:radiotherapy*; D014807:Vitamin D / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D045930:Anabolic Agents; D000900:Anti-Bacterial Agents; D014807:Vitamin D; D014810:Vitamin E
Konzeption und Systematik der klinischen Mammakarzinom-Nachbehandlung